title: Dyslipidaemia in the Middle East: Current status and a call for action.
abstract: The increase in the cardiovascular disease (CVD)-associated mortality rate in the Middle East (ME) is among the highest in the world. The aim of this article is to review the current prevalence of dyslipidaemia and known gaps in its management in the ME region, and to propose initiatives to address the burden of dyslipidaemia. Published literature on the epidemiology of dyslipidaemia in the ME region was presented and discussed at an expert meeting that provided the basis of this review article. The high prevalence of metabolic syndrome, diabetes, familial hypercholesterolaemia (FH) and consanguineous marriages, in the ME region, results in a pattern of dyslipidaemia (low high-density lipoprotein cholesterol and high triglycerides) that is different from many other regions of the world. Early prevention and control of dyslipidaemia is of paramount importance to reduce the risk of developing CVD. Education of the public and healthcare professionals and developing preventive programs, FH registries and regional guidelines on dyslipidaemia are the keys to dyslipidaemia management in the ME region.
authors: Department of Clinical Biochemistry, Sultan Qaboos University Hospital, Muscat, Oman. Electronic address: khalid77@squ.edu.om.
authors: Khalid
authors: K
authors: Al Rasadi
authors: Heart and Vascular Institute -Cleveland Clinic, Abu Dhabi, United Arab Emirates.
authors: Wael
authors: W
authors: Almahmeed
authors: Department of Cardiac Sciences, King Fahad Cardiac Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
authors: Khalid F
authors: KF
authors: AlHabib
authors: Laboratory of Biochemistry and Molecular Therapeutics, Faculty of Pharmacy, Saint-Joseph University of Beirut, Beirut, Lebanon.
authors: Marianne
authors: M
authors: Abifadel
authors: Baghdad Teaching Hospital, Medical City, Iraqi Board for Medical Specialization, Baghdad, Iraq.
authors: Hasan Ali
authors: HA
authors: Farhan
authors: Department of Internal Medicine, Alhada Armed Forces Hospital, Taif, Saudi Arabia.
authors: Saud
authors: S
authors: AlSifri
authors: St Joseph University Faculty of Medicine and Hotel Dieu Hospital, Beirut, Lebanon.
authors: Selim
authors: S
authors: Jambart
authors: Department of Medicine, Faculty of Medicine, Kuwait University, Kuwait.
authors: Mohammad
authors: M
authors: Zubaid
authors: Department of Clinical Biochemistry, King Abdulaziz University, Abdullah Sulayman, Jeddah, Saudi Arabia.
authors: Zuhier
authors: Z
authors: Awan
authors: Department of Clinical Biochemistry, Sultan Qaboos University Hospital, Muscat, Oman.
authors: Khalid
authors: K
authors: Al-Waili
authors: School of Medical Sciences, University of New South Wales, Sydney, Australia.
authors: Philip
authors: P
authors: Barter
mesh_terms: D002309:Cardiology / Q000379:methods / Q000592:standards*; D016208:Databases, Factual; D050171:Dyslipidemias / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy*; D005260:Female; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000453:epidemiology*; D008297:Male; D008877:Middle East; D015995:Prevalence; D012042:Registries; D012307:Risk Factors
keywords: Cardiovascular disease; Dyslipidaemia; Familial hypercholesterolaemia; Guidelines; Middle east; Prevalence